vs

Side-by-side financial comparison of BXP, Inc. (BXP) and Surgery Partners, Inc. (SGRY). Click either name above to swap in a different company.

Surgery Partners, Inc. is the larger business by last-quarter revenue ($885.0M vs $872.1M, roughly 1.0× BXP, Inc.). BXP, Inc. runs the higher net margin — 15.3% vs -1.7%, a 16.9% gap on every dollar of revenue. On growth, Surgery Partners, Inc. posted the faster year-over-year revenue change (2.4% vs 0.8%). Over the past eight quarters, Surgery Partners, Inc.'s revenue compounded faster (11.1% CAGR vs 1.3%).

BXP Inc., operating as Boston Properties, is a leading U.S. real estate investment trust focused on owning, managing and developing high-quality Class A commercial office properties across major U.S. metro markets, serving diverse corporate, tech and professional service tenants.

United Surgical Partners International, Inc. (USPI) is an American ambulatory care company based in Dallas, Texas. It was founded by Don Steen in 1998.

BXP vs SGRY — Head-to-Head

Bigger by revenue
SGRY
SGRY
1.0× larger
SGRY
$885.0M
$872.1M
BXP
Growing faster (revenue YoY)
SGRY
SGRY
+1.6% gap
SGRY
2.4%
0.8%
BXP
Higher net margin
BXP
BXP
16.9% more per $
BXP
15.3%
-1.7%
SGRY
Faster 2-yr revenue CAGR
SGRY
SGRY
Annualised
SGRY
11.1%
1.3%
BXP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BXP
BXP
SGRY
SGRY
Revenue
$872.1M
$885.0M
Net Profit
$133.0M
$-15.0M
Gross Margin
Operating Margin
12.5%
Net Margin
15.3%
-1.7%
Revenue YoY
0.8%
2.4%
Net Profit YoY
53.0%
86.2%
EPS (diluted)
$1.69
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BXP
BXP
SGRY
SGRY
Q1 26
$872.1M
Q4 25
$877.1M
$885.0M
Q3 25
$871.5M
$821.5M
Q2 25
$868.5M
$826.2M
Q1 25
$865.2M
$776.0M
Q4 24
$858.6M
$864.4M
Q3 24
$859.2M
$770.4M
Q2 24
$850.5M
$762.1M
Net Profit
BXP
BXP
SGRY
SGRY
Q1 26
$133.0M
Q4 25
$248.4M
$-15.0M
Q3 25
$-121.7M
$-22.7M
Q2 25
$89.0M
$-2.5M
Q1 25
$61.2M
$-37.7M
Q4 24
$-228.9M
$-108.5M
Q3 24
$83.6M
$-31.7M
Q2 24
$79.6M
$-15.5M
Gross Margin
BXP
BXP
SGRY
SGRY
Q1 26
Q4 25
58.8%
Q3 25
59.3%
Q2 25
59.2%
Q1 25
59.2%
Q4 24
59.7%
Q3 24
59.5%
Q2 24
59.8%
Operating Margin
BXP
BXP
SGRY
SGRY
Q1 26
Q4 25
12.5%
Q3 25
12.9%
Q2 25
13.5%
Q1 25
8.0%
Q4 24
14.7%
Q3 24
7.9%
Q2 24
11.1%
Net Margin
BXP
BXP
SGRY
SGRY
Q1 26
15.3%
Q4 25
28.3%
-1.7%
Q3 25
-14.0%
-2.8%
Q2 25
10.2%
-0.3%
Q1 25
7.1%
-4.9%
Q4 24
-26.7%
-12.6%
Q3 24
9.7%
-4.1%
Q2 24
9.4%
-2.0%
EPS (diluted)
BXP
BXP
SGRY
SGRY
Q1 26
$1.69
Q4 25
$1.56
$-0.11
Q3 25
$-0.77
$-0.18
Q2 25
$0.56
$-0.02
Q1 25
$0.39
$-0.30
Q4 24
$-1.46
$-0.86
Q3 24
$0.53
$-0.25
Q2 24
$0.51
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BXP
BXP
SGRY
SGRY
Cash + ST InvestmentsLiquidity on hand
$512.8M
$239.9M
Total DebtLower is stronger
$3.6B
Stockholders' EquityBook value
$7.7B
$1.7B
Total Assets
$25.1B
$8.1B
Debt / EquityLower = less leverage
2.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BXP
BXP
SGRY
SGRY
Q1 26
$512.8M
Q4 25
$1.5B
$239.9M
Q3 25
$861.1M
$203.4M
Q2 25
$447.0M
$250.1M
Q1 25
$398.1M
$229.3M
Q4 24
$1.3B
$269.5M
Q3 24
$1.4B
$221.8M
Q2 24
$685.4M
$213.5M
Total Debt
BXP
BXP
SGRY
SGRY
Q1 26
Q4 25
$3.6B
Q3 25
$3.5B
Q2 25
$3.5B
Q1 25
$3.4B
Q4 24
$3.3B
Q3 24
$3.1B
Q2 24
$3.0B
Stockholders' Equity
BXP
BXP
SGRY
SGRY
Q1 26
$7.7B
Q4 25
$5.1B
$1.7B
Q3 25
$5.0B
$1.7B
Q2 25
$5.3B
$1.7B
Q1 25
$5.3B
$1.7B
Q4 24
$5.4B
$1.8B
Q3 24
$5.8B
$1.9B
Q2 24
$5.8B
$2.0B
Total Assets
BXP
BXP
SGRY
SGRY
Q1 26
$25.1B
Q4 25
$26.2B
$8.1B
Q3 25
$26.0B
$7.9B
Q2 25
$25.6B
$8.0B
Q1 25
$25.4B
$7.9B
Q4 24
$26.1B
$7.9B
Q3 24
$26.4B
$7.5B
Q2 24
$25.5B
$7.5B
Debt / Equity
BXP
BXP
SGRY
SGRY
Q1 26
Q4 25
2.10×
Q3 25
2.00×
Q2 25
1.98×
Q1 25
1.98×
Q4 24
1.83×
Q3 24
1.63×
Q2 24
1.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BXP
BXP
SGRY
SGRY
Operating Cash FlowLast quarter
$103.4M
Free Cash FlowOCF − Capex
$90.6M
FCF MarginFCF / Revenue
10.2%
Capex IntensityCapex / Revenue
1.5%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$195.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BXP
BXP
SGRY
SGRY
Q1 26
Q4 25
$407.8M
$103.4M
Q3 25
$274.2M
$83.6M
Q2 25
$353.1M
$81.3M
Q1 25
$210.0M
$6.0M
Q4 24
$383.7M
$111.4M
Q3 24
$286.1M
$65.2M
Q2 24
$367.1M
$82.8M
Free Cash Flow
BXP
BXP
SGRY
SGRY
Q1 26
Q4 25
$362.7M
$90.6M
Q3 25
$231.6M
$63.8M
Q2 25
$281.5M
$57.9M
Q1 25
$152.6M
$-16.7M
Q4 24
$312.5M
$89.1M
Q3 24
$234.5M
$45.0M
Q2 24
$332.4M
$55.9M
FCF Margin
BXP
BXP
SGRY
SGRY
Q1 26
Q4 25
41.4%
10.2%
Q3 25
26.6%
7.8%
Q2 25
32.4%
7.0%
Q1 25
17.6%
-2.2%
Q4 24
36.4%
10.3%
Q3 24
27.3%
5.8%
Q2 24
39.1%
7.3%
Capex Intensity
BXP
BXP
SGRY
SGRY
Q1 26
1.5%
Q4 25
5.1%
1.4%
Q3 25
4.9%
2.4%
Q2 25
8.2%
2.8%
Q1 25
6.6%
2.9%
Q4 24
8.3%
2.6%
Q3 24
6.0%
2.6%
Q2 24
4.1%
3.5%
Cash Conversion
BXP
BXP
SGRY
SGRY
Q1 26
Q4 25
1.64×
Q3 25
Q2 25
3.97×
Q1 25
3.43×
Q4 24
Q3 24
3.42×
Q2 24
4.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BXP
BXP

Lease$818.2M94%
Parking and other$30.8M4%
Development and management services$9.2M1%

SGRY
SGRY

Private Insurance$460.5M52%
Government Revenue$368.6M42%
Other$19.8M2%
Self Pay Revenue$19.6M2%
Other Patient Service Revenue Sources$16.5M2%

Related Comparisons